Esperion Therapeutics, Inc. 4
4 · Esperion Therapeutics, Inc. · Filed Aug 8, 2014
Insider Transaction Report
Form 4
Lalwani Narendra D.
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2014-08-07+250,000→ 250,000 totalExercise: $15.33Exp: 2024-08-07→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]25% of option vests on August 1, 2015 and the remainder shall vest in equal quarterly installments over a three (3) year period thereafter.